Top Stories in Cardiovascular Disease Prevention: New Strategies for Risk Reduction - 3/12/20

Target Audience

This activity was developed for physicians including Eisenhower medical staff along with nurses and ancillary staff.

Learning Objectives

At the end of this presentation, participants should be better able to:

  • Learn how to perform cardiovascular risk assessment in primary prevention and define very high risk status according to latest guidelines
  • Understand the latest trials of non-statin therapies and the appropriate use of these therapies according to latest guidelines
  • Understand the cardiovascular risks associated with diabetes and the role and appropriate use of newer therapies to reduce risk
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Course opens: 
03/12/2020
Course expires: 
03/12/2021
Cost:
$0.00
Parent activity set: 
Rating: 
0

Dr. Wong reports research funding through the University of California, Irvine from Amgen, Amarin, and Novartis, is on the advisory committee for Esperion, and speaker bureau for Amarin, Sanofi, and Esperion. Dr. Wong does not intend to reference unlabeled/unapproved uses of drugs or products in his presentation.

Education Planning Committee disclosures:

Mohammad Mojarad, MD (Chair): No relevant commercial interests or relationships to report
Khaldoun Alnabelsi, MD: No relevant commercial interests or relationships to report
Constantin Dasanu, MD, PhD: No relevant commercial interest or relationships to report
Chris Flores, MD: No relevant commercial interests or relationships to report
Raila Horne, Psy.D: No relevant commercial interests or relationships to report
Vicki Koceja, PhD, RN, FAAMA: No relevant commercial interests or relationships to report
Lisa Lindley, MD: No relevant commercial interests or relationships to report
Lester Padilla, MD: No relevant commercial interests or relationships to report
Maja Ruetschi, MD: No relevant commercial interests or relationships to report
Phil Shaver, MD: No relevant commercial interests or relationships to report
John Stansell, MD: No relevant commercial interests or relationships to report
Charles Willis, MBA: Consults for Pfizer, Inc
Melissa Ketchum, CHCP, FACEHP: No relevant commercial interests or relationships to report
Melissa Velasquez: No relevant commercial interests or relationships to report

 

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.